Results 31 to 40 of about 178,708,228 (184)

The establishment of a bisphosphonate⁃related osteonecrosis of the jaw rat model

口腔疾病防治, 2017
With the wide use of bisphosphonates in bone diseases such as osteoporosis and bone metastases of ma⁃ lignant tumors, bisphosphonate⁃related osteonecrosis of the jaw has gained widely attention as a severe side effect. Ani⁃ mal model is a useful way to
LIU Jie, TANG Hua
doaj   +1 more source

Osteonecrosis of the jaw in patients taking atorvastatin: case series [PDF]

, 2022
Osteonecrosis of the jawbones commonly seen in patients taking bisphosphonates, denosumab, and several antiangiogenic medications with several oral factors such as tooth extraction or dental infection ...
Nordin, Jenizan, Ghazali, Ahmad Badruddin   +1 more
core   +1 more source

Symposium: Imaging modalities for drug-related osteonecrosis of the jaw (4), CT and MR imaging findings of antiresorptive agent-related osteonecrosis of the jaws/medication-related osteonecrosis of the jaw (secondary publication)

Japanese Dental Science Review, 2019
Summary: Generally, CT and MR images of antiresorptive agent-related osteonecrosis of the jaw (ARONJ)/medication-related osteonecrosis of the jaw (MRONJ) show nonspecific findings as seen in active osteomyelitis．However, there are some characteristics as
Akira Baba, Hiroya Ojiri, Tazuko K. Goto, Koshi Ikeda, Hideomi Yamauchi, Nobuhiro Ogino, Takuji Mogami   +6 more
doaj   +1 more source

Local delivery of hydrogel encapsulated vascular endothelial growth factor for the prevention of medication-related osteonecrosis of the jaw [PDF]

, 2021
The anti-angiogenic effects of bisphosphonates have been hypothesized as one of the major etiologic factors in the development of medication-related osteonecrosis of the jaw (MRONJ), a severe debilitating condition with limited treatment options.
Petcu, Eugen Bogdan, Hamlet, Stephen, Sharma, Dileep, Vaquette, Cedryck, Ivanovski, Saso, Ramamurthy, Poornima   +5 more
core   +1 more source

Drug assumption and awareness about adverse drug reactions. The right to know. The case of the bone-modyfing agents: a systematic review

Frontiers in Oral Health
IntroductionMedication-related osteonecrosis of the Jaw (MRONJ) is an adverse drug reaction that affects the mandible and maxilla of patients exposed to BMA and AA therapies, causing the progressive destruction and death of bone.
Rodolfo Mauceri, Rodolfo Mauceri, Sonia Arduini, Martina Coppini, Martina Coppini, Martina Coppini, Monica Bazzano, Isabel Trujillo, Giuseppina Campisi   +8 more
doaj   +1 more source

Potential Dental Risk Factors of Bisphosphonate-related Osteonecrosis of the Jaws [PDF]

Journal of Postgraduate Medicine, Education and Research
Osteonecrosis of the jaw (ONJ) is a rare side effect observed in patients receiving high-dose, frequent osteoclast inhibitor treatments. The jawbone is particularly susceptible due to its high turnover rate.
Sonal Maurya, Charan Kamal Kaur, Umesh Kumar, Akhil Rajput, Jayveer Puri   +4 more
doaj   +1 more source

Biphosphonates-related osteonecrosis of the jaw [PDF]

, 2019
The relationship between osteonecrosis of the jaw and bisphosphonate therapy has been describedrecently. Although bisphosphonates have a long list of benefits in the treatment of patients with bonemetastases, an increasing number of reports describe the ...
Białożyk-Mularska, Katarzyna; Department of Oncology, Radiotherapy and Gynecologic Oncology, Collegium Medicum, Nicolaus Copernicus University, 85-796 Bydgoszcz, Poland, Roszkowski, Krzysztof; Department of Oncology, Radiotherapy and Gynecologic Oncology, Collegium Medicum, Nicolaus Copernicus University, 85-796 Bydgoszcz, Poland   +1 more
core   +1 more source

Mandibular Osteonecrosis Associated with Antacid Therapy (Esomeprazole)

European Journal of Case Reports in Internal Medicine, 2019
Introduction: Osteonecrosis of the jaw has been consistently reported in the literature associated to the high-dose intravenous bisphosphonate therapy. However, osteonecrosis can also occur in patients who have other risk factors.
Simone Marconcini, Enrica Giammarinaro, Saverio Cosola, Anna Maria Genovesi, Ugo Covani   +4 more
doaj   +1 more source

The awareness and practice of dentists regarding medication-related osteonecrosis of the jaw and its prevention: a cross-sectional survey

BMC Oral Health, 2021
Background Accurate documentation of a patient’s prior medication use and awareness of side effects associated with anti-osteoporotic agents can assist dentists to prevent medication-related osteonecrosis of the jaw. I aimed to determine the awareness of
A. Lum Han
doaj   +1 more source

Utility of quantitative standardized uptake value from pre-operative bone SPECT/CT for predicting post-surgical MRONJ healing response

EJNMMI Research
Background Medication-related osteonecrosis of the jaw (MRONJ) is a challenging condition often associated with long-term use of anti-resorptive medications.
Jung-Hyun Park, Da-Mi Yoon, Hai-Jeon Yoon, Jin-Woo Kim   +3 more
doaj   +1 more source